Ian Mortimer insider trades

Open-market stock purchases and sales by Ian Mortimer, PRESIDENT & CEO at Xenon Pharmaceuticals Inc, from SEC Form 4 filings since Mar 17, 2015.

Recent trades

DateStockTradeValue
Mar 13, 2026XENE Xenon Pharmaceuticals IncSold$404K
Mar 12, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 10, 2026XENE Xenon Pharmaceuticals IncSold$677K
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$2.6M
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$3.7M
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$4M
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$743K
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$609K
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$150K
Mar 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$1.3M
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$1.9M
Mar 9, 2026XENE Xenon Pharmaceuticals IncSold$1.3M
Jan 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Jan 9, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Jan 2, 2026XENE Xenon Pharmaceuticals IncBought (not open market)—
Jan 2, 2026XENE Xenon Pharmaceuticals IncSold$1.7M
Jan 2, 2026XENE Xenon Pharmaceuticals IncSold$92.6K
Dec 8, 2025XENE Xenon Pharmaceuticals IncSold$93.1K
Dec 8, 2025XENE Xenon Pharmaceuticals IncSold$402K

Companies traded

  • XENE Xenon Pharmaceuticals Inc: 5 buys, 25 sales, last Mar 13, 2026

Get free alerts when Ian Mortimer files a new trade →